1-1 of 1
Marilyn Davis, R.N.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Transplant Outcomes after Topotecan-Melphalan-Cyclophosphamide (TMC) Conditioning for Autologous Stem Cell Transplantation for Multiple Myeloma. Comparison to Melphalan 200 mg/M2 (MEL200).

Michele Donato, MD, Ana Aleman, MD, Donna Weber, MD, Michael Wang, MD, Muzaffer Qazilbasch, MD, Marilyn Davis, R.N., Linda Roden, MD, Floralyn Mendoza, BS, Richard Champlin, MD, Sergio Giralt, MD
Journal: Blood
Blood (2005) 106 (11): 1177.
https://doi.org/10.1182/blood.V106.11.1177.1177
Published: 2005